CPT code 17266 identifies the destruction of a malignant cutaneous lesion on the trunk, arms, or legs when the lesion exceeds 4.0 cm in diameter. This procedural code captures services using chemosurgery, cryosurgery, electrosurgery, or other destructive techniques. Accurate use of the code affects clinical documentation, billing consistency, and national reporting for skin cancer interventions performed in ambulatory settings.

Key payers in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines payer coverage patterns, coding benchmarks, and relevant policy or documentation considerations that influence reimbursement and compliance for destructive procedures on malignant skin lesions.

Readers will find a concise clinical context for CPT code 17266, guidance on typical sites of service, and an overview of the types of benchmarks and policy updates addressed in the full publication. The content summarizes national implications for billing integrity and operational workflows when treating large malignant skin lesions in outpatient and ambulatory surgical environments. Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.